Beware the approaching silent killer influenza - hVIVO

Latest HVIVO Press Release: 19.09.19 Unaudited Interim Results for the Six Months Ended 30 June 2019

MENUMENU

Services
- - - Human challenge full-service solution
    - Industry leading provider of viral challenge studies
      
      See Our Solution
  - - hVIVO Challenge Models
  - - Laboratory Services
Investors
- - - Investors
      
      hVIVO’s shares are listed on the AIM market of the London Stock Exchange under the HVO ticker.
      
      This area is dedicated to keeping shareholders and potential investors informed.
News, Media & Events
- - - News, Media & Events
      
      A source for the latest press releases, scientific publications and other media as well as details of investor and scientific events that we attend and host across the world.
About Us
- - - About Us
      Our Mission is to build a profitable clinical development services business supporting product development for our clients through human challenge studies to establish early proof of concept.
      
      More about hVIVO
  - - LATEST PRESS RELEASE
      
      06.08.19 hVIVO Successfully Completes RSV Challenge Study in Older Adults
    - UPCOMING EVENTS
      
      World Vaccine Congress Europe 201929 Oct - 31 Oct, Barcelona, Spain, Palau de Congressos de Catalunya
Volunteers
Careers
Contact Us

Beware the approaching silent killer influenza

December 29, 2014 11:45 am

Follow @hVIVO_UK

Comments are closed here.

Whether you’re a potential customer, job seeker, health professional or an investor, you can find the best way to contact us from the list below.

Contact Us

Terms & Conditions
Careers
Sitemap

© 2019 Copyright hVIVO Services Limited. All rights reserved.

Privacy Policy | Cookie Policy